107 related articles for article (PubMed ID: 9500678)
1. Integrin receptor-targeted transfer peptides for efficient delivery of antisense oligodeoxynucleotides.
Bachmann AS; Surovoy A; Jung G; Moelling K
J Mol Med (Berl); 1998 Feb; 76(2):126-32. PubMed ID: 9500678
[TBL] [Abstract][Full Text] [Related]
2. Specifically designed polymeric nanospheres increase cellular uptake of unmodified antisense ODNs.
Tondelli L; Laus M; Ricca A; Citro G
Nucleosides Nucleotides; 1999; 18(6-7):1677-9. PubMed ID: 10474244
[TBL] [Abstract][Full Text] [Related]
3. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.
Del Bufalo D; Cucco C; Leonetti C; Citro G; D'Agnano I; Benassi M; Geiser T; Zon G; Calabretta B; Zupi G
Br J Cancer; 1996 Aug; 74(3):387-93. PubMed ID: 8695353
[TBL] [Abstract][Full Text] [Related]
4. Use of a constrain phage displayed-peptide library for the isolation of peptides binding to HIV-1 nucleocapsid protein (NCp7).
Lener D; Benarous R; Calogero RA
FEBS Lett; 1995 Mar; 361(1):85-8. PubMed ID: 7890046
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.
Citro G; Szczylik C; Ginobbi P; Zupi G; Calabretta B
Br J Cancer; 1994 Mar; 69(3):463-7. PubMed ID: 8123474
[TBL] [Abstract][Full Text] [Related]
6. Highly efficient cellular uptake of c-myb antisense oligonucleotides through specifically designed polymeric nanospheres.
Tondelli L; Ricca A; Laus M; Lelli M; Citro G
Nucleic Acids Res; 1998 Dec; 26(23):5425-31. PubMed ID: 9826768
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody-mediated inhibition of RNA binding and annealing activities of HIV type 1 nucleocapsid protein.
Tanchou V; Delaunay T; De Rocquigny H; Bodeus M; Darlix JL; Roques B; Benarous R
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):983-93. PubMed ID: 7529035
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides.
Citro G; Perrotti D; Cucco C; D'Agnano I; Sacchi A; Zupi G; Calabretta B
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7031-5. PubMed ID: 1495997
[TBL] [Abstract][Full Text] [Related]
9. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
Gryaznov S; Skorski T; Cucco C; Nieborowska-Skorska M; Chiu CY; Lloyd D; Chen JK; Koziolkiewicz M; Calabretta B
Nucleic Acids Res; 1996 Apr; 24(8):1508-14. PubMed ID: 8628685
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 nucleocapsid protein activates transient melting of least stable parts of the secondary structure of TAR and its complementary sequence.
Bernacchi S; Stoylov S; Piémont E; Ficheux D; Roques BP; Darlix JL; Mély Y
J Mol Biol; 2002 Mar; 317(3):385-99. PubMed ID: 11922672
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activities of fluorescent acridine-containing HIV-1 nucleocapsid proteins for investigation of nucleic acid-NCp7 interactions.
Dong CZ; De Rocquigny H; Rémy E; Mellac S; Fournié-Zaluski MC; Roques BP
J Pept Res; 1997 Oct; 50(4):269-78. PubMed ID: 9352465
[TBL] [Abstract][Full Text] [Related]
12. Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMR.
Morellet N; de Rocquigny H; Mély Y; Jullian N; Déméné H; Ottmann M; Gérard D; Darlix JL; Fournie-Zaluski MC; Roques BP
J Mol Biol; 1994 Jan; 235(1):287-301. PubMed ID: 8289249
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
14. Time-resolved fluorescence investigation of the human immunodeficiency virus type 1 nucleocapsid protein: influence of the binding of nucleic acids.
Bombarda E; Ababou A; Vuilleumier C; Gérard D; Roques BP; Piémont E; Mély Y
Biophys J; 1999 Mar; 76(3):1561-70. PubMed ID: 10049336
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of human leukemia HL-60 cells by an antisense phosphodiester oligonucleotide encapsulated into fusogenic liposomes.
Kondoh M; Matsuyama T; Suzuki R; Mizuguchi H; Nakanishi T; Nakagawa S; Tsutsumi Y; Nakanishi M; Sato M; Mayumi T
Biol Pharm Bull; 2000 Aug; 23(8):1011-3. PubMed ID: 10963315
[TBL] [Abstract][Full Text] [Related]
16. Analysis of NCp7-dependent activation of HIV-1 cDNA integration and its conservation among retroviral nucleocapsid proteins.
Poljak L; Batson SM; Ficheux D; Roques BP; Darlix JL; Käs E
J Mol Biol; 2003 Jun; 329(3):411-21. PubMed ID: 12767826
[TBL] [Abstract][Full Text] [Related]
17. Nucleic acid sequence discrimination by the HIV-1 nucleocapsid protein NCp7: a fluorescence study.
Vuilleumier C; Bombarda E; Morellet N; Gérard D; Roques BP; Mély Y
Biochemistry; 1999 Dec; 38(51):16816-25. PubMed ID: 10606514
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
Szczylik C; Skórski T; Malaguarnera L; Hetman J; Chen ST; Calabretta B
Folia Histochem Cytobiol; 1996; 34(3-4):129-34. PubMed ID: 8967957
[TBL] [Abstract][Full Text] [Related]
19. Protamine-fragment peptides fused to an SV40 nuclear localization signal deliver oligonucleotides that produce antisense effects in prostate and bladder carcinoma cells.
Benimetskaya L; Guzzo-Pernell N; Liu ST; Lai JC; Miller P; Stein CA
Bioconjug Chem; 2002; 13(2):177-87. PubMed ID: 11906253
[TBL] [Abstract][Full Text] [Related]
20. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
Normand N; Valamanesh F; Savoldelli M; Mascarelli F; BenEzra D; Courtois Y; Behar-Cohen F
Mol Vis; 2005 Mar; 11():184-91. PubMed ID: 15761390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
